ES2139525A1 - Use of whey-derived products as cytoprotectors and cicatrizants. - Google Patents

Use of whey-derived products as cytoprotectors and cicatrizants.

Info

Publication number
ES2139525A1
ES2139525A1 ES009702404A ES9702404A ES2139525A1 ES 2139525 A1 ES2139525 A1 ES 2139525A1 ES 009702404 A ES009702404 A ES 009702404A ES 9702404 A ES9702404 A ES 9702404A ES 2139525 A1 ES2139525 A1 ES 2139525A1
Authority
ES
Spain
Prior art keywords
whey
derived products
cicatrizants
cytoprotectors
cocktail
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009702404A
Other languages
Spanish (es)
Other versions
ES2139525B1 (en
Inventor
Sanchez Pedro Cuevas
Gallego Guillermo Gimenez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES9702404A priority Critical patent/ES2139525B1/en
Publication of ES2139525A1 publication Critical patent/ES2139525A1/en
Application granted granted Critical
Publication of ES2139525B1 publication Critical patent/ES2139525B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

Use of whey-derived products as cytoprotectors and cicatrizants, specifically for preparing a drug which contains a cocktail of growth factors and other bioactive substances. In addition to drugs, the whey-derived products can be used to prepare creams for topical use, intended for pathological conditions in which there is a structural and functional change in the mucous membranes or ulcerative erosion thereof. <IMAGE>
ES9702404A 1997-11-17 1997-11-17 USE OF DERIVATIVES OF THE WHEY AS CITOPROTECTORS AND SCARS. Expired - Fee Related ES2139525B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9702404A ES2139525B1 (en) 1997-11-17 1997-11-17 USE OF DERIVATIVES OF THE WHEY AS CITOPROTECTORS AND SCARS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9702404A ES2139525B1 (en) 1997-11-17 1997-11-17 USE OF DERIVATIVES OF THE WHEY AS CITOPROTECTORS AND SCARS.

Publications (2)

Publication Number Publication Date
ES2139525A1 true ES2139525A1 (en) 2000-02-01
ES2139525B1 ES2139525B1 (en) 2000-10-16

Family

ID=8301218

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9702404A Expired - Fee Related ES2139525B1 (en) 1997-11-17 1997-11-17 USE OF DERIVATIVES OF THE WHEY AS CITOPROTECTORS AND SCARS.

Country Status (1)

Country Link
ES (1) ES2139525B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1303284A4 (en) * 2000-07-13 2004-05-12 Gropep Ltd Compositions and methods for the treatment of skin damage

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2472385A1 (en) * 1979-12-27 1981-07-03 Sederma Sa Extracts of natural biological substances used in cosmetology - prepd. by thermo-degradation and molecular filtration
FR2533438A2 (en) * 1979-12-27 1984-03-30 Sederma Sarl Use of growth factors and biological extracts containing the latter in cosmetology
WO1992000994A1 (en) * 1990-07-13 1992-01-23 Gropep Pty. Ltd. Growth-promoting agent
WO1995000155A1 (en) * 1993-06-23 1995-01-05 Viable Bioproducts Ltd. Method for the improvement of wound healing and compositions therefor
WO1995029933A1 (en) * 1994-04-28 1995-11-09 Gropep Pty. Ltd. Modified milk growth factor
WO1996034614A1 (en) * 1995-05-02 1996-11-07 Gropep Pty. Ltd. Method of preventing or treating alimentary tract damage due to chemotherapy or radiation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2472385A1 (en) * 1979-12-27 1981-07-03 Sederma Sa Extracts of natural biological substances used in cosmetology - prepd. by thermo-degradation and molecular filtration
FR2533438A2 (en) * 1979-12-27 1984-03-30 Sederma Sarl Use of growth factors and biological extracts containing the latter in cosmetology
WO1992000994A1 (en) * 1990-07-13 1992-01-23 Gropep Pty. Ltd. Growth-promoting agent
WO1995000155A1 (en) * 1993-06-23 1995-01-05 Viable Bioproducts Ltd. Method for the improvement of wound healing and compositions therefor
WO1995029933A1 (en) * 1994-04-28 1995-11-09 Gropep Pty. Ltd. Modified milk growth factor
WO1996034614A1 (en) * 1995-05-02 1996-11-07 Gropep Pty. Ltd. Method of preventing or treating alimentary tract damage due to chemotherapy or radiation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1303284A4 (en) * 2000-07-13 2004-05-12 Gropep Ltd Compositions and methods for the treatment of skin damage
US7410946B2 (en) 2000-07-13 2008-08-12 Novozymes Biopharma Au Limited Method for treating damage in intact skin comprising administering a composition comprising basic milk growth factors in amounts higher than those in milk

Also Published As

Publication number Publication date
ES2139525B1 (en) 2000-10-16

Similar Documents

Publication Publication Date Title
WO2000027405A8 (en) Hyaluronic acid gel, process for the preparation thereof and medical materials containing the same
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
NO871791D0 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING SYRELABLE SUBSTANCES FOR ORAL USE.
ZA991077B (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia.
IL89702A0 (en) Water soluble ibuprofen compositions,processes for the preparation thereof and pharmaceutical compositions containing the same
DE69827929D1 (en) SKIN CARE PRODUCTS
MX22877A (en) PROCEDURE FOR THE PREPARATION OF PYRIMIDS, PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITION INCLUDING IT
AR012125A1 (en) A SALT OF A COMPOUND DERIVED FROM CARBOXYLLIC NAFTIRIDINE ACID, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PROCEDURE TO PREPARE IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
SE0104421D0 (en) New composition
IL148870A (en) 2&#39;-substituted 1,1&#39;-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
AR059764A2 (en) PROCESS TO PREPARE A PHARMACEUTICAL COMPOSITION OF RITONAVIR AND COMPOSITION OBTAINED
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
AR021347A1 (en) A PHARMACEUTICAL COMPOSITION CONTAINING SISPHOSPHONIC ACID (S) OR SALT (S) OF THE SAME AND A PREPARATION PROCESS OF THE SAME
AU4846690A (en) Polyunsaturated fatty acid derivatives, pharmaceutical compositions containing the same, method for the preparation thereof, and their use as medicament
AU5561690A (en) Improvements in or relating to pharmaceutical preparations
PL320916A1 (en) Derivatives of piperasino 2,5-dione as modulators of drug-fastness in respect to amny drugs
EP0879597A4 (en) Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same
CA2429639A1 (en) Stable azithromycin monohydrate
DE3888036D1 (en) Optically active compound, process for its preparation and liquid-crystalline composition containing it.
GB0108722D0 (en) Creatine and/or creatine derivatives used as cosmetic preparations containing moisturizers
AU6732190A (en) Use of guanidinoacetic acid to induce an increase of the creatine contents in muscles
BR9911775A (en) Use of nano-food in final food products for humans and animals
ES2139525A1 (en) Use of whey-derived products as cytoprotectors and cicatrizants.
AU1258000A (en) Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
AU3025695A (en) Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants, and its use

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000201

Kind code of ref document: A1

Effective date: 20000201

PC2A Transfer of patent
FD1A Patent lapsed

Effective date: 20041118